Catalyst Wire Dossier Catalyst Wire Dossier

Plonmarlimab

Plonmarlimab · TJ Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Plonmarlimab, covering 2025-06-24 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis [Phase 2]

See pricing